Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile
Bishal Gyawali, MD, PhD, FASCO

@oncology_bg

Personal acc. Med Onc. A/Prof. @queensoncology @QueensuPHS. #cancerpolicy #cancergroundshot. Pubs: tinyurl.com/oncobg Talks- tinyurl.com/mrprevnp

ID: 3511138520

linkhttps://oncologybg.com/ calendar_today10-09-2015 03:23:26

34,34K Tweet

15,15K Followers

805 Following

Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo
Bishal Gyawali, MD, PhD, FASCO
@oncology_bg

2 months ago

NEW FDA- Make Surrogate Endpoints Great Again! 100% of cancer drug approvals since May 2025 have been on the basis of surrogate endpoints. The latest approval in fact celebrates “no detriment” in OS. 🤦‍♂️

NEW FDA- Make Surrogate Endpoints Great Again! 100% of cancer drug approvals since May 2025 have been on the basis of surrogate endpoints. The latest approval in fact celebrates “no detriment” in OS. 🤦‍♂️